A phase 2 study of abemaciclib plus pembrolizumab for patients with hormone receptor positive (HR+), HER2 negative (HER2-) metastatic breast cancer (MBC) Meeting Abstract
| Authors: | Rugo, H.; Tolaney, S.; Dickler, M.; Kabos, P.; Ho, C. L.; Wildiers, H.; Jerusalem, G.; Ales-Martinez, J. E.; Hossain, A.; Johnston, E.; Gianni, L. |
| Abstract Title: | A phase 2 study of abemaciclib plus pembrolizumab for patients with hormone receptor positive (HR+), HER2 negative (HER2-) metastatic breast cancer (MBC) |
| Meeting Title: | 2016 San Antonio Breast Cancer Symposium (SABCS) |
| Journal Title: | Cancer Research |
| Volume: | 77 |
| Issue: | 4 Suppl. |
| Meeting Dates: | 2016 Dec 6-10 |
| Meeting Location: | San Antonio, TX |
| ISSN: | 0008-5472 |
| Publisher: | American Association for Cancer Research |
| Date Published: | 2017-02-01 |
| Language: | English |
| ACCESSION: | WOS:000397999000074 |
| DOI: | 10.1158/1538-7445.sabcs16-ot2-01-07 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract: OT2-01-07 -- Source: Wos |
Altmetric
Citation Impact
BMJ Impact Analytics
Related MSK Work